News
Hosted on MSN23d
FDA approves new RSV treatment for infantsRSV can cause severe infection of the lungs in infants and older adults, according to Mayo Clinic. Researchers say this antibody helps reduce lower respiratory infections that need medical attention.
Latest medical research on lung disease. Learn about the symptoms of chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer along with the latest treatment information.
Researchers are trialing a new process of healing damaged lungs. AddedAug 24th, 2022 A new project has been launched to ensure Australians battling sarcoma don't miss out on promising new anti ...
Rationale The pathogenesis of respiratory syncytial virus (RSV) bronchiolitis in infants remains poorly understood. Mouse models implicate pulmonary T cells in the development of RSV disease. T cell ...
LOS ANGELES -- The US Food and Drug Administration (FDA) approved the first respiratory syncytial virus (RSV) vaccine on Wednesday. The vaccine, named Arexvy, is approved for the prevention of lower ...
RSV accounts for 47% of hospitalized bronchiolitis and pneumonia cases in newborns under 6 months 1, making it a major concern for families. For some families, that first encounter with RSV comes too ...
In a similar fashion to the aforementioned symptom of lung damage, it could suggest that your body is getting worn out from battling to breathe while dealing with a reduced oxygen supply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results